Nancy C. Paduano Professor and Chair of Pediatrics
New York Presbyterian/Weill Cornell Medicine
New York, NY, United States
Dr. Sallie Permar is the Nancy C. Paduano Professor and Chair of the Department of Pediatrics at Weill Cornell Medicine, Pediatrician-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center, and Professor of Immunology and Microbial Pathogenesis at the Weill Cornell Graduate School of Medical Sciences. As a physician-scientist focusing on the prevention and treatment of neonatal viral infections, Dr. Permar leads a research laboratory investigating immune protection against vertical transmission of neonatal viral pathogens, namely HIV and cytomegalovirus (CMV). She has made important contributions to the development of vaccines for prevention of vertical HIV transmission, defining both innate and adaptive immune responses that are associated with protection against infant HIV acquisition and is leading the development of HIV vaccine strategies in preclinical maternal/infant nonhuman primate models and translation of this work for clinical vaccine trials in infants. She has also defined determinants of congenital and perinatal CMV transmission, developing the first nonhuman primate model of congenital CMV infection and leading human cohort studies that have defined immune correlates of protection necessary to guide vaccine development. Dr. Permar received a Ph.D. in Microbiology/Immunology from Johns Hopkins Bloomberg School of Public Health, an M.D. from Harvard Medical School and completed clinical training in pediatric infectious diseases at Boston Children’s Hospital. She has received several prestigious investigator awards including the Presidential Early Career Award in Science and Engineering and E. Mead Johnson Award from the Society of Pediatric Research. She has been inducted into the American Society of Clinical Investigation and is a Fellow of the American Academy of Microbiology and the American Association of Advancement of Science. In 2020, she received the Oswald Avery Award for Early Achievement from the Infectious Diseases Society of America and in 2022 received the Excellence in Science Mid-Career Investigator Award from the Federation of American Societies for Experimental Biology. She serves on the board of the National CMV Foundation and is Director of the National Institute of Child Health and Development Pediatric Scientist Development Program.
Disclosure(s): No financial relationships to disclose
257 - Vaccines for Herpes Viruses
Saturday, October 14, 2023
1:45 PM – 3:00 PM US ET
2873 - CMV Vaccines: Where Are We Now?
Saturday, October 14, 2023
2:35 PM – 3:00 PM US ET